- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
N-Nitroso Binimetinib
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Binimetinib treats melanoma by stopping cancer cells from growing. Melanoma is an invasive form of skin cancer. This medication comes as a tablet that you can take by mouth with a glass of water as directed.N-Nitroso Binimetinib is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Binimetinib CAS NO:NA chemically represented as 5-((4-Bromo-2-fluorophenyl)(nitroso)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide. Synchemia is the leading manufacturing and exporter of N-Nitroso Binimetinib . We supply N-Nitroso Binimetinib with detailed characterization data compliance with regulatory guidelines.
.png)
| Product name | N-Nitroso Binimetinib |
| SRC CAT No | SRC-N014448 |
| CAS No | NA |
| Mol.F. | C17H14BrF2N5O4 |
| Mol.Wt. | 470.2 |
| Related CAS No. | NA |
| Inv Status | Custom Synthesis |
